According to a study published in JAMA Internal Medicine, outpatient process measures need a fair balance between measures for underuse and overuse of clinical services.
At an attempt to improve quality of healthcare, a number of clinical performance measures have been developed to improve clinician and institutional performance. However, the influence of these measures on changing clinical practice on a large scale have been questioned. A primary question being raised, and which was the objective of the current study in JAMA Internal Medicine, is that a focus on underuse and rewarding physicians to do more would tilt the balance toward overutilization.
The authors of the study, in an attempt to understand the influence of outpatient process measures on underuse and overuse, identified all outpatient and emrgency department (ED) process measures included in major national measure programs till mid-2012. Inpatient measures were excluded from the evaluation, as were outcomes measures, settings other than outpatient or ED, and nonclinical aspects of care. A total of 521 measures of care were included in the study from across 16 measure collections.
A detailed evaluation of these measures showed that nearly 92% (477) targeted underuse while just over 6% (34) targeted overuse. Less than 3% (14) addressed misuse. Of the 16 measure collections, the authors found only 3 that included a good percentage of overuse measures (≥10%) while more than 50% did not include any overuse measures. Underuse measures, the authors write, covered all categories of clinical service, while overuse measures were restricted and addressed either diagnostic imaging or medication prescription.
According to Erika Newton, MD, MPH, one of the study's senior authors, "Our findings suggest that, by focusing almost single-mindedly on identifying and penalizing underuse, current outpatient performance measures may well foster a culture of ‘more is better’─and inadvertently encourage overuse of care." The authors believe their findings highlight the need to anticipate and monitor intended and unintended consequences of measure programs and the need for a fair balance between measureing underuse and overuse of clinical services across the spectrum.
Contributor: More Informed Management of Preeclampsia Is Necessary
November 29th 2023At present, it is difficult for clinicians to identify patients at greatest risk for developing preeclampsia with severe features and tailor treatment plans for them; this difficulty increases costs significantly.
Read More
Understanding the Unmet Need for Therapies to Treat Rare Bile Duct Cancer
May 24th 2022On this episode of Managed Care Cast, we bring you an excerpt of an interview with a co-chair of the 2022 Cholangiocarcinoma Foundation (CCF) annual conference, held earlier this year, about the significant unmet therapy needs facing most patients with this rare cancer.
Listen
Provisional CDC data show that US babies gained roughly a year in life expectancy in 2022; study findings indicate that the COVID-19 pandemic significantly raised the risk of preterm birth for expectant California mothers; New York Attorney General Letitia James said about 4 million New Yorkers were affected by a data breach of the medical transcription company Perry Johnson & Associates.
Read More
A Look at Racial Disparities in US HPV Vaccine Uptake
March 1st 2022On this episode of Managed Care Cast, Leslie Cofie, PhD, MPH, an assistant professor of health education and promotion at the College of Health and Human Performance, East Carolina University, discusses his work on identifying and addressing racial disparities in human papillomavirus (HPV) vaccine uptake in the United States.
Listen
Gene Therapy Success in UK Likely Depends on Overcoming Education, Psychological Support Challenges
November 27th 2023Education, psychological support, and implementation guidance are the top unmet needs identified by investigators from the United Kingdom concerning gene therapy use for hemophilia.
Read More